9th Annual Biomarkers Congress
Parkinson's Disease Therapeutics Conference
The New York Academy of Sciences
7 World Trade Center, 250, Greenwich St. at Barclay St., 40th fl.
New York, NY
http://www.nyas.org/Events/Detail.aspx?cid=a56cc95d-81f9-413d-9be6-27b32cd788e4
Parkinson's Disease Therapeutics Conference
New York Academy of Sciences 

Schedule of Presentations:

Wednesday, September 30, 2009
08:00:00 Breakfast
08:30:00 Welcome by J. William Langston, MD J. William Langston,
08:45:00 Session I: Novel Therapeutic Targets
09:00:00 Granulocyte-colony Stimulating Factor (G-CSF) as a Neuroprotective Therapy for Parkinson's Disease Mathias Baehr
09:15:00 Discovery of mGluR4 Potentiators for Symptomatic and Disease-Modifying Treatment of PD P. Jeffrey Conn
09:30:00 Therapeutic Development of siRNA Targeting Alpha-Synuclein David Bumcrot
10:30:00 Networking Break/Poster Viewing
11:00:00 Session I: Novel Therapeutic Targets (cont'd)
11:15:00 Validation of TorsinA as a Target for PD therapy in Mammalian Models David G. Standaert
11:30:00 Novel Phosphodiesterase Inhibitors for Parkinson's Disease Gretchen Snyder
12:00:00 Lunch/Poster Viewing
13:15:00 Session II: Research Tools and Resources
13:20:00 Image-Guided Convective Delivery of AAV Vectors Krystof Bankiewicz
13:30:00 Parkinson's Disease, Ashkenazi Jews and LRRK2 Susan Bressman
13:45:00 P1 Artificial Chromosome Transgenic Mice as Models for Progressive Parkinson Disease Robert Nussbaum
15:00:00 Characterization of Alpha Synuclein in Human Fluids & Brain as a Biomarker for PD Michael Schlossmacher
15:15:00 Networking Break/Poster Viewing
15:45:00 How Should One Design the First Alpha-Synuclein Efficacy Trial? Franz Hefti
15:45:00 Session III: Hot Topics in PD
16:00:00 (How) Can GWAS Help Drug Developers? Andrew Singleton
16:45:00 Closing Remarks
17:00:00 Cocktail Reception/Poster Viewing
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.